These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 37984828

  • 1. Narrowband ultraviolet B phototherapy combined with intralesional injection of either latanoprost or platelet-rich plasma for stable nonsegmental vitiligo.
    Fawzy M, Al-Mokadem S, Alshereef M, Elkholy B.
    Photodermatol Photoimmunol Photomed; 2024 Jan; 40(1):e12929. PubMed ID: 37984828
    [Abstract] [Full Text] [Related]

  • 2. Combined treatment with fractional carbon dioxide laser, autologous platelet-rich plasma, and narrow band ultraviolet B for vitiligo in different body sites: A prospective, randomized comparative trial.
    Abdelghani R, Ahmed NA, Darwish HM.
    J Cosmet Dermatol; 2018 Jun; 17(3):365-372. PubMed ID: 28834191
    [Abstract] [Full Text] [Related]

  • 3. A comparative study of combined microneedling and narrowband ultraviolet B phototherapy versus their combination with topical latanoprost in the treatment of vitiligo.
    Neinaa YME, Lotfy SS, Ghaly NR, Doghaim NN.
    Dermatol Ther; 2021 Mar; 34(2):e14813. PubMed ID: 33497514
    [Abstract] [Full Text] [Related]

  • 4. The effect of platelet-rich plasma on the outcome of short-term narrowband-ultraviolet B phototherapy in the treatment of vitiligo: a pilot study.
    Ibrahim ZA, El-Ashmawy AA, El-Tatawy RA, Sallam FA.
    J Cosmet Dermatol; 2016 Jun; 15(2):108-16. PubMed ID: 26695436
    [Abstract] [Full Text] [Related]

  • 5. Whole-body and targeted narrowband ultraviolet B phototherapy effectively stabilize acral vitiligo with negligible repigmentation beyond wrists and ankles: Results from a split-body randomized controlled trial.
    Thind A, Vinay K, Mehta H, Bishnoi A, Kumaran MS, Parsad D.
    Photodermatol Photoimmunol Photomed; 2024 Mar; 40(2):e12960. PubMed ID: 38480997
    [Abstract] [Full Text] [Related]

  • 6. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
    Tawfik YM, Abd Elazim NE, Abdel-Motaleb AA, Mohammed RAA, Tohamy AMA.
    J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
    [Abstract] [Full Text] [Related]

  • 7. Treatment outcome and persistence of repigmentation from narrow-band ultraviolet B phototherapy in vitiligo.
    Silpa-Archa N, Weerasubpong P, Junsuwan N, Yothachai P, Supapueng O, Wongpraparut C.
    J Dermatolog Treat; 2019 Nov; 30(7):691-696. PubMed ID: 30474443
    [Abstract] [Full Text] [Related]

  • 8. Combination treatment by 10 600 nm ablative fractional carbon dioxide laser and narrowband ultraviolet B in refractory nonsegmental vitiligo: a prospective, randomized half-body comparative study.
    Shin J, Lee JS, Hann SK, Oh SH.
    Br J Dermatol; 2012 Mar; 166(3):658-61. PubMed ID: 22050270
    [Abstract] [Full Text] [Related]

  • 9. Effects of a preceding fractional carbon dioxide laser on the outcome of combined local narrowband ultraviolet B and topical steroids in patients with vitiligo in difficult-to-treat areas.
    Vachiramon V, Chaiyabutr C, Rattanaumpawan P, Kanokrungsee S.
    Lasers Surg Med; 2016 Feb; 48(2):197-202. PubMed ID: 26175036
    [Abstract] [Full Text] [Related]

  • 10. A comparative interventional study of narrowband ultraviolet B alone and narrowband ultraviolet B in combination with microneedling in patients with stable vitiligo.
    Kaur A, Barman KD, Sahoo B, Choudhary P.
    Photodermatol Photoimmunol Photomed; 2023 Jul; 39(4):357-363. PubMed ID: 36419200
    [Abstract] [Full Text] [Related]

  • 11. Targeted broadband ultraviolet b phototherapy produces similar responses to targeted narrowband ultraviolet B phototherapy for vitiligo: a randomized, double-blind study.
    Asawanonda P, Kijluakiat J, Korkij W, Sindhupak W.
    Acta Derm Venereol; 2008 Jul; 88(4):376-81. PubMed ID: 18709309
    [Abstract] [Full Text] [Related]

  • 12. Combined therapy for resistant vitiligo lesions: NB-UVB, microneedling, and topical latanoprost, showed no enhanced efficacy compared to topical latanoprost and NB-UVB.
    Stanimirovic A, Kovacevic M, Korobko I, Šitum M, Lotti T.
    Dermatol Ther; 2016 Sep; 29(5):312-316. PubMed ID: 27356486
    [Abstract] [Full Text] [Related]

  • 13. Apremilast in Combination with Narrowband UVB in the Treatment of Vitiligo: A 52-Week Monocentric Prospective Randomized Placebo-Controlled Study.
    Khemis A, Fontas E, Moulin S, Montaudié H, Lacour JP, Passeron T.
    J Invest Dermatol; 2020 Aug; 140(8):1533-1537.e2. PubMed ID: 32004567
    [Abstract] [Full Text] [Related]

  • 14. Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial.
    Lim HW, Grimes PE, Agbai O, Hamzavi I, Henderson M, Haddican M, Linkner RV, Lebwohl M.
    JAMA Dermatol; 2015 Jan; 151(1):42-50. PubMed ID: 25230094
    [Abstract] [Full Text] [Related]

  • 15. Comparison between 308-nm excimer light alone versus 308-nm excimer light and platelet-rich plasma in the treatment for localized vitiligo.
    Elsaadany AE, El-Khalawany M, Elshahid AR, Seddeik Abdel-Hameed AK.
    J Cosmet Dermatol; 2022 Jul; 21(7):2826-2831. PubMed ID: 34719101
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of using fractional CO2 laser plus NB-UVB versus NB-UVB alone in inducing marginal repigmentation of vitiligo lesions.
    Ghasemloo S, Gauthier Y, Ghalamkarpour F.
    J Dermatolog Treat; 2019 Nov; 30(7):697-700. PubMed ID: 30592235
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness and safety of tofacitinib combined with narrowband ultraviolet B phototherapy for patients with refractory vitiligo in real-world clinical practice.
    Song H, Hu Z, Zhang S, Yang L, Liu Y, Wang T.
    Dermatol Ther; 2022 Nov; 35(11):e15821. PubMed ID: 36114601
    [Abstract] [Full Text] [Related]

  • 18. Clinical evaluation of interrupted versus continuous narrowband ultraviolet B phototherapy in nonsegmental vitiligo treatment: A prospective randomized comparative study.
    Anbar TS, Mohammed SS, Mohamed DM, Abdel-Rahman AT.
    Dermatol Ther; 2019 Nov; 32(6):e13117. PubMed ID: 31606939
    [Abstract] [Full Text] [Related]

  • 19. The use of intralesional corticosteroid combined with narrowband ultraviolet B in vitiligo treatment: clinical, histopathologic, and histometric evaluation.
    El-Domyati M, Anbar TS, Yehia M, Abdel-Aziz RTA.
    Int J Dermatol; 2022 May; 61(5):582-590. PubMed ID: 34643271
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.